Unlocking the mysteries of early human development through blastoid models

It’s one of life’s most defining moments-;that crucial step in embryonic development, when an indistinct ball of cells rearranges itself into the orderly three-layered structure that sets the stage for all to come.

XOMA to buy Kinnate; A pain biotech’s small IPO

Plus, news about Blueprint Medicines, Sosei Group and Poxel: XOMA to buy Kinnate Biopharma: The biotech royalty aggregator said it would pay $2.33 per share

February 17, 2024

More state Medicaid programs consider covering GLP-1 drugs

Most state Medicaid programs don’t cover the new class of weight loss drugs for obesity, but that could soon change. Half of those that don’t

October 23, 2024

Pliant shares spike on exploratory study results of lead drug in chronic liver disease

Pliant Therapeutics shared early-stage biomarker and imaging results, suggesting that patients with a chronic liver disease who received its drug had improved liver function compared

September 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.